AMAlireza Mirzaei

Alireza Mirzaei

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Alireza Mirzaei has a total of 124 co-authors. Here are the top co-authors by number of shared publications:

  • Khodamorad Jamshidi

    Bone and Joint Reconstruction Research Center, Department of Orthopedics, School of Medicine, Iran University of Medical Sciences, Tehran, Iran

    17 shared publications
  • Khodamorad Jamshidi

    Bone and Joint Reconstruction Research Center, Department of Orthopedics, School of Medicine, Iran University of Medical Sciences, Tehran, Iran

    16 shared publications
  • Abolfazl Bagherifard

    Bone and Joint Reconstruction Research Center, Department of Orthopedics, School of Medicine, Iran University of Medical Sciences, Tehran, Iran

    13 shared publications
  • Azade Amini Kadijani

    Department of Orthopedics, Bone and Joint Reconstruction Research Center, School of Medicine, Iran University of Medical Sciences, Tehran, Iran

    9 shared publications
  • Abolfazl Akbari

    Colorectal Research Center, Iran University of Medical Sciences, Tehran, Iran

    7 shared publications
  • Abolfazl Bagherifard

    Bone and Joint Reconstruction Research Center, Department of Orthopedics, School of Medicine, Iran University of Medical Sciences, Tehran, Iran

    6 shared publications

Latest Publications

  • Chondromyxoid Fibroma of the Metatarsals: Outcomes of En Bloc Resection and Intercalary Fibular Allograft Reconstruction in a Series of 9 Patients

    by Khodamorad Jamshidi, Seyed Mohammad Mohammadi, Shahabaldin Beheshti Fard, Alireza Mirzaei

    Background: The optimal surgical and reconstructive strategies for chondromyxoid fibroma (CMF) of the metatarsal bones remain controversial. This study examined the outcomes of en bloc resection followed by fibular strut allograft reconstruction in 9 patients with aggressive or recurrent metatarsal CMF. Methods: Nine patients were included in this retrospective case series. Indications for this approach included thin cortex, cortical breakdown, or local recurrence. Outcomes were recurrence, radiographic union, limb function, and surgical complications. Results: At a median follow-up of 8 years, no local recurrence was recorded in this series. Radiographic union at both host-allograft junctions was achieved in 8 of 9 patients. The median Musculoskeletal Tumor Society score was 30. The median Toronto Extremity Salvage Score was 96. Complications were infrequent and manageable. Conclusion: En bloc resection followed by fibular strut allograft reconstruction appears to provide durable local tumor control and encouraging functional outcomes in patients with aggressive or locally recurrent metatarsal CMF. Level of Evidence: IV (Therapeutic study; case series

  • Toward Standardized Reporting in Nontraumatic Osteonecrosis of the Femoral Head: Recommendations for Clinical Study Design and Reporting

    by Edward Y. Cheng, Alireza Mirzaei, Rafael J. Sierra, Stuart B. Goodman, Philippe Hernigou, Romil R. Parikh, Kyung-Hoi Koo, Nobuhiko Sugano, Dewei Zhao, Wolf Drescher, et al.

  • Allograft-Prosthesis Composites for the Reconstruction of the Distal Femur After the Resection of a Bone Tumor in Childhood

    by Khodamorad Jamshidi, Abolfazl Bagherifard, Amin Hamidzadah Khiavi, Alireza Mirzaei

    Background: The tibial physis is responsible for about 30% of the growth in the limb 1 . Therefore, preservation of this growth potential in skeletally immature patients undergoing distal femoral tumor resection and reconstruction is important. Reconstruction with use of an expandable prosthesis has a high failure rate 2,3 . Osteoarticular allograft reconstruction of the distal femur allows for the preservation of the proximal tibial plateau; however, the small size of the child’s tibial plateau relative to the femoral condyle of the allograft creates challenges in size matching 2,4,5 . To address this issue, resurfacing the osteoarticular allograft with the appropriate femoral component of a total knee prosthesis, referred to as allograft-prosthesis composite (APC) reconstruction, could be regarded as a viable alternative 2,6 . Description: An anterior longitudinal incision is made encompassing the biopsy tract, either medial or lateral to the midline, depending on the tumor mass. The roof of the adductor canal is opened to expose the femoral vein and artery for protection. The resection length is based on the length of medullary involvement as measured on magnetic resonance imaging (MRI), plus an additional 2-cm margin. The bone marrow from the proximal femur is sent for frozen-section analysis in order to ensure that an adequate margin has been achieved. Depending on the MRI findings, the capsule, collateral ligaments, and cruciate ligaments are incised, and the meniscus on the tibial plateau is preserved, with consideration given to achieving a negative margin. An appropriately sized osteoarticular allograft with the retained capsule and ligaments is obtained from a standard bone bank. The femoral component of the unconstrained total knee prosthesis is matched for size with the patient’s tibial plateau and is fixed to the distal end of the osteoarticular allograft with use of bone cement. The resurfaced allograft is fixed to the host bone with a bridging plate. The ligaments and capsule of the allograft are sutured as closely as possible to their counterparts in the proximal tibia. Knee stability is evaluated at the end of the procedure. Two crossed pins are utilized to fix the knee in 15° flexion to prevent joint subluxation in cases of knee instability and are removed after 2 weeks. Alternatives: One alternative is reconstruction with use of an expandable prosthesis; however, high failure rates have been reported, including due to stem loosening, lengthening failure, and periprosthetic fracture 3 . Moreover, currently available expandable prostheses require a minimum resection length substantially longer than the actual tumor length, leading to unnecessary removal of healthy bone and loss of valuable bone stock in growing children 2,3 . Osteoarticular allograft presents challenges related to the small size of the tibial plateau in pediatric patients relative to the allograft femoral condyle, leading to a Charcot joint developing in all patients emerging around 8 years postoperatively 4,5 . Rationale: APC reconstruction preserves the proximal tibial growth plate and retains more bone stock for future revisions. This technique offers benefits over the use of an osteoarticular allograft, including improved knee function and a reduced risk of osteoarthritic changes, and can even be performed on patients 2 . Important Tips: Choose a medial or lateral approach on the basis of the dominant tumor location. During tumor resection, take care to preserve the neurovascular bundle. After opening the adductor canal, detach the medial gastrocnemius head from the distal femur to facilitate genicular artery ligation and the separation of the vascular bundle from the lesion. Try to use an allograft with remaining ligamentous and capsular structures, as attaching these to their host counterparts can enhance the restoration of joint stability. The compression plate should fully cover the allografts and secure them to the host bone, and compression should be maintained with at least 4 screws. The selected cruciate-retaining femoral component of the THA should be secured to the distal allograft with high-viscosity cement according to the total knee method. Acronyms and Abbreviations: rAPC = resurfaced allograft-prosthesis composites TKA = total knee arthroplasty MRI = magnetic resonance imaging DVT = deep vein thrombosis PE = pulmonary embolism MSTS = Musculoskeletal Tumor Society ROM = range of motion DJD = degenerative joint disease

  • Top Cited Papers

    Nontraumatic Osteonecrosis of the Femoral Head: An International Evidence-Based Clinical Practice Guideline*

    by Edward Y. Cheng, Alireza Mirzaei, Stuart B. Goodman, Quanjun Cui, Michael A. Mont, Lynne C. Jones, The Arco Clinical Practice Guideline Workgroup

    Background: Nontraumatic osteonecrosis of the femoral head (ONFH) can lead to major disability in patients of all ages. It presents at various levels of severity and can be either symptomatic or asymptomatic. There is a vast array of management strategies. Treatment is often subject to physician bias. Clinical practice guidelines that are broad-based, internationally developed, consensus-driven, and strictly evidence-based are needed. The aim of this guideline by the Association Research Circulation Osseous (ARCO) was to develop international evidence-based recommendations to assist physicians and patients in managing ONFH. Methods: ARCO convened an international, multidisciplinary guideline panel that was balanced to minimize potential bias from conflicts of interest. The Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach was utilized, including GRADE Evidence-to-Decision frameworks. The panel prioritized clinical questions, defined criteria for the systematic review of evidence, evaluated the statistical analysis, and, by consensus, approved recommendation statements, which were then subject to external review by content experts and stakeholders (a health policy-maker and a patient). Results: The panel agreed on 12 recommendations for the diagnosis, evaluation, and management of ONFH. Conclusions: Key recommendations of these guidelines require accurately staging ONFH and determining when pain may be due to ONFH. They establish principles for optimal decision-making by assessing the quality of evidence backing various treatments and identifying numerous areas for additional investigation. Clinical Relevance: This international evidence-based guideline provides standardized recommendations for the diagnosis and management of nontraumatic ONFH. It synthesizes all available evidence using GRADE methodology and offers practical, consensus-supported guidance for accurate staging, imaging selection, treatment decision-making, and the identification of patients who would benefit from joint-preserving interventions. The guideline supports clinicians in reducing practice variation, improving diagnostic accuracy, and optimizing treatment pathways for patients with ONFH.


  • One-stage surgical correction of Shepherd’s crook deformity in fibrous dysplasia using fibular strut allograft augmentation: a retrospective case-series

    by Khodamorad Jamshidi, Abolfazl Bagherifard, Amin Hamidzadah Khiavi, Alireza Mirzaei

    Shepherd's crook deformity is a characteristic complication of fibrous dysplasia (FD) of the femur, leading to coxa vara and mechanical instability. Two-stage surgical approaches involve initial valgus osteotomy followed by delayed intramedullary femoral stabilization, prolonged treatment, and increasing morbidity. This study evaluates a one-stage surgical correction that employs fibular strut allograft augmentation for both the femoral neck and shaft. A retrospective review was performed on 17 patients with Shepherd's crook deformity who underwent one-stage hip lag screw and side plate fixation with fibular strut allograft augmentation of the femoral neck and shaft between 2002 and 2022. Radiographic and clinical outcomes were assessed, including neck-shaft angle (NSA) restoration, fixation stability, graft incorporation, and functional improvement. The median follow-up of the patients was 96 months. The mean preoperative NSA was 93° (SD: 13.5°), improving significantly to 130° (SD: 5°) at the latest follow-up (p < 0.001). Stable fixation was achieved in 16 of 17 patients, with one case of fixation failure. Fibular graft resorption was noted in six patients but did not compromise fixation. Clinically, postoperative pain, limping, and activity limitations improved substantially, though seven patients experienced persistent restrictions in outdoor activities. The average limb shortening was 3.5 cm before the operation and 0.9 cm at the end of the follow-up. One-stage correction of Shepherd's crook deformity using lag hip screw fixation and fibular strut allograft augmentation could be a viable alternative to staged procedures, though further studies are needed to confirm its efficacy and generalizability.

  • Incidence and descriptive characteristics of multifocal soft tissue sarcomas: a retrospective cohort study over two decades

    by Khodamorad Jamshidi, Abolfazl Bagherifard, Seyyed Saeed Khabiri, Alireza Mirzaei

    Background: Soft tissue sarcomas (STS) are a rare group of adult malignancies. Multifocal type of STS is very rare. For this reason, the incidence rate, characteristic features, and oncologic outcomes of this condition are largely unknown. In this study, we report the incidence rate, characteristic features, and oncologic outcomes of multifocal STS. Methods: Medical profiles of STS patients who were treated in our university hospital between 2000 and 2022 were retrospectively reviewed. Sixteen patients with multifocal STS were identified, of whom 12 were included in the study. Pathological features, anatomical distribution, number of lesions, temporal sequence, and oncologic outcomes were extracted for the medical records. Results: Multifocal STS comprised 0.49% of all STS cases. The mean age of the patients was 54.1 yrs. Male involvement was more frequently observed (83.3%). The most frequently observed histological subtype was myxoid liposarcoma (n=5), followed by leiomyosarcoma (n=3) and low-grade fibrosarcoma (n=3). The metachronous pattern was more frequent than the synchronous pattern (8 vs. 4). The average time interval between the diagnosis of initial and secondary lesions was 12.4 mos. At a mean follow-up of 9.4 yrs, two patients (16.7%) developed local recurrence, and one patient (8.3%) developed lung metastasis. No tumor-related death was observed until the last follow-up. Conclusion: The reported incidence of multifocal STS was in line with that reported in earlier studies. However, the oncological outcomes have markedly improved. These observations could be attributed to the advancements in imaging modalities and therapeutic methods. Level of evidence: IV

  • Incidence and Risk Factors for Nontraumatic Osteonecrosis of the Femoral Head in Kidney Transplant Recipients: A Comparison of Two Eras (1985–2000 and 2001–2024)

    by Edward Y. Cheng, Arthur J. Matas, Lee Houachee, Alireza Mirzaei

    Background: Historically, osteonecrosis of the femoral head (ONFH) was a major problem following kidney transplantation, occurring in up to 5%–11% of recipients. The development of new immunosuppressive agents permitted steroid minimization protocols, and consequently, the incidence of ONFH has decreased. We studied ONFH trends over four decades and evaluated risk factors in two immunosuppressive eras, pre‐ and post‐2001. Patients and Methods: Steroid minimization protocols at our center started in 2000. We reviewed records of 1st kidney transplants from January 1985 to May 2024 and compared ONFH incidence and risk factors between the two eras: Era 1 (January 1985–December 31, 2000) and Era 2 (January 2001–May 2024). Cox regression was used to assess for independent factors associated with a higher or lower incidence of ONFH. Results: ONFH incidence in Era 1 was 7.2%; Era 2, 1.1% ( p < 0.001). In Era 1, increased risk was associated with heavier weight (HR: 1.017, 95% CI: 1.010–1.023, p < 0.001) and mTOR inhibitors (HR: 4.258, 95% CI: 1.726–10.506, p = 0.002); and decreased risk with diabetes (HR: 0.362, 95% CI: 0.270‐0.486, p < 0.001), and statins (HR: 0.452, 95% CI: 0.327–0.625, p < 0.001). In Era 2, increased risk was associated with steroid use (HR: 2.096, 95% CI: 1.071–4.100, p = 0.031) and decreased risk with mycophenolate (HR: 0.471, 95% CI: 0.237–0.935, p = 0.032). Conclusion: The incidence of ONFH in KTRs has dramatically decreased in the modern immunosuppressive era. Diabetes, statin use, and immunosuppressive medications, specifically mTOR inhibitors and mycophenolate, appear to have varying impacts depending on the immunosuppressive era.


  • Osteonecrosis: A More Appropriate Term than Avascular Necrosis–Pathophysiologic Rationale

    by Edward Y. Cheng, Alireza Mirzaei, Nobuhiko Sugano, Philippe Hernigou, Lynne C. Jones, Kyung-Hoi Koo, Wolf R. Drescher, Quanjun Cui, Rafael J. Sierra, Stuart B. Goodman, et al.


  • Open Access

    Osteoarticular allograft versus prosthetic allograft composites: which reconstruction method results in superior outcomes following the resection of proximal femur tumor in adolescent and preadolescent patients?

    by Khodamorad Jamshidi, Abolfazl Bagherifard, Seyyed Saeed Khabiri, Alireza Mirzaei

    Primary malignant tumors of the proximal femur in children are rare, and there is no consensus about the optimal reconstruction method for this condition. While methods for biological reconstruction—such as vascularized fibular allograft and rotationplasty—and nonbiological options like expandable endoprosthesis exist as reconstructive choices, each method has its distinct advantages and disadvantages. In this study, we compared the outcomes of osteoarticular allograft (OAA) with allograft-prosthetic component (APC) in reconstructing the proximal femur in a cohort of adolescent and preadolescent patients. Twenty patients aged between 8 and 13 years with primary malignant bone tumors of the proximal femur who were managed with either OAA or APC reconstruction were included. The median follow-up was 71 months (range 24–140). The primary outcome of interest was limb function evaluated by the Musculoskeletal Tumor Society (MSTS) score. Secondary outcomes of interest were surgical complications. The median MSTS score of the patients was 23 (range 20–25) in the OAA group and 26 (range 23–27) in the APC group (P = 0.003). Postoperative complications in the OAA group included two nonunions (18.1%), two infections (18.1%), six degenerative joint diseases (54.5%), and one allograft fracture (9.1%). The postoperative complications in the APC group included one nonunion (11.1%), one dislocation (11.1%), and two allograft fractures (22.2%). Allograft fractures were managed with revision and replacement with a tumor prosthesis. No revision was done to address the DJD in the OAA group. OA and APC reconstructions of the proximal femur following tumor resection in adolescent and preadolescent patients each have their benefits and associated complications. However, APC reconstruction appears to provide superior limb function and a lower incidence of postoperative complications.